Clinical Trial Results

Condition: Breast Cancer Location: South Carolina 5 trials found

Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008

N/AOBSERVATIONAL Angers +4 more

Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype

PHASE2INTERVENTIONAL Graz +4 more

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

PHASE1, PHASE2INTERVENTIONAL Fullerton, California +4 more

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

PHASE3INTERVENTIONAL Innsbruck +4 more